Your browser doesn't support javascript.
loading
CRISPR-based large-scale modeling of loss-of-function mutations to investigate mechanisms of stress resistance in cancer.
Simeoni, Fabrizio; Loukas, Ioannis; Wilson, Thomas Stuart; Scaffidi, Paola.
Afiliação
  • Simeoni F; Cancer Epigenetics Laboratory, The Francis Crick Institute, NW1 1AT London, UK. Electronic address: fabrizio.simeoni@crick.ac.uk.
  • Loukas I; Cancer Epigenetics Laboratory, The Francis Crick Institute, NW1 1AT London, UK.
  • Wilson TS; Cancer Epigenetics Laboratory, The Francis Crick Institute, NW1 1AT London, UK.
  • Scaffidi P; Cancer Epigenetics Laboratory, The Francis Crick Institute, NW1 1AT London, UK; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy. Electronic address: paola.scaffidi@crick.ac.uk.
STAR Protoc ; 4(1): 102097, 2023 03 17.
Article em En | MEDLINE | ID: mdl-36853711
Dissecting mechanisms driving subclone expansion in primary cancers has been challenging. Here, we present a protocol to systematically disrupt entire gene networks and assess the functional impact of this perturbation on cancer cell fitness. By combining arrayed CRISPR libraries and high-content microscopy, we describe steps to identify classes of genes whose inactivation promotes resistance to environmental challenges faced by cancer cells during tumor growth or upon therapy. A proof-of-principle interrogation of the epigenetic regulatory network is described. For complete details on the use and execution of this protocol, please refer to Loukas et al. (2022).1.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article